2-(4-morpholinyl)-4h-1-benzopyran-4-one has been researched along with ku-0060648 in 1 studies
Studies (2-(4-morpholinyl)-4h-1-benzopyran-4-one) | Trials (2-(4-morpholinyl)-4h-1-benzopyran-4-one) | Recent Studies (post-2010) (2-(4-morpholinyl)-4h-1-benzopyran-4-one) | Studies (ku-0060648) | Trials (ku-0060648) | Recent Studies (post-2010) (ku-0060648) |
---|---|---|---|---|---|
6 | 0 | 0 | 18 | 0 | 15 |
Protein | Taxonomy | 2-(4-morpholinyl)-4h-1-benzopyran-4-one (IC50) | ku-0060648 (IC50) |
---|---|---|---|
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform | Homo sapiens (human) | 0.0001 | |
Neuronal acetylcholine receptor subunit alpha-4 | Rattus norvegicus (Norway rat) | 0.005 | |
Neuronal acetylcholine receptor subunit beta-2 | Rattus norvegicus (Norway rat) | 0.005 | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | Homo sapiens (human) | 0.004 | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | Homo sapiens (human) | 0.0005 | |
Serine/threonine-protein kinase mTOR | Homo sapiens (human) | 10 | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | Homo sapiens (human) | 0.59 | |
DNA-dependent protein kinase catalytic subunit | Homo sapiens (human) | 0.005 | |
Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.005 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bardos, J; Cano, C; Golding, BT; Griffin, RJ; Hardcastle, IR; Parveen, N; Payne, SL; Peacock, M; Rodriguez-Aristegui, S | 1 |
1 other study(ies) available for 2-(4-morpholinyl)-4h-1-benzopyran-4-one and ku-0060648
Article | Year |
---|---|
Mapping the ATP-binding domain of DNA-dependent protein kinase (DNA-PK) with coumarin- and isocoumarin-derived inhibitors.
Topics: Adenosine Triphosphate; Antineoplastic Agents; Binding Sites; Chromones; Coumarins; DNA-Activated Protein Kinase; Humans; Inhibitory Concentration 50; Isocoumarins; Structure-Activity Relationship | 2010 |